Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shorter steroid regimen may prevent chemo allergies just as well

NCT ID NCT03598426

Completed Symptom relief Sponsor: Loma Linda University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested three ways of giving the steroid dexamethasone to prevent allergic reactions from the chemotherapy drug paclitaxel in 90 women with breast or gynecologic cancer. One group took oral dexamethasone the night before and morning of treatment, another got it intravenously just before chemo, and a third got both. The goal was to see if the shorter IV-only method works as well as the standard longer oral course, which could make pre-treatment easier for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dexamethasone (a steroid drug)
What this could lead to
If it works, this could show that a simpler, shorter IV steroid regimen is just as good as the standard longer oral course for preventing allergic reactions to paclitaxel.
What could go wrong
This is a small, single-center study with only 90 patients, so results may not apply to everyone. Also, it compares different ways of giving the same drug, so no new treatment is being discovered.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic disease breast cancer female reproductive organ cancer hypersensitivity reaction disease drug allergy prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERSENSITIVITY REACTIONS

Contacts and locations

Locations

  • Loma Linda University Cancer Center

    Loma Linda, California, 92354, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.